Hastie K.M.Li H.Bedinger D.Schendel S.L.Moses Dennison S.Li K.Rayaprolu V.Yu X.Mann C.Zandonatti M.Avalos R.D.Zyla D.Buck T.Hui S.Shaffer K.Hariharan C.Yin J.Olmedillas E.Enriquez A.Parekh D.Abraha M.Feeney E.Horn G.Q.Aldon Y.Ali H.Aracic S.Cobb R.R.Federman R.S.Fernandez J.M.Glanville J.Green R.Grigoryan G.Lujan Hernandez A.G.Ho D.D.Kuan-Ying A. HuangIngraham J.Jiang W.Kellam P.Kim C.Kim M.Kim H.M.Kong C.Krebs S.J.Lan F.Lang G.Lee S.Leung C.L.Liu J.Lu Y.MacCamy A.McGuire A.T.Palser A.L.Rabbitts T.H.Tehrani Z.R.Sajadi M.M.Sanders R.W.Sato A.K.Schweizer L.Seo J.Shen B.Snitselaar J.L.Stamatatos L.Tan Y.Tomic M.T.van Gils M.J.Youssef S.Yu J.Yuan T.Z.Zhang Q.Peters B.Tomaras G.D.Germann T.Saphire E.O.CoVIC-DB team2023-01-112023-01-1120210036-8075https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116366228&doi=10.1126%2fscience.abh2315&partnerID=40&md5=c597c45fe07b211d0f2175c3e6af827fhttps://scholars.lib.ntu.edu.tw/handle/123456789/627139[SDGs]SDG3Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyjournal article10.1126/science.abh2315345548262-s2.0-85116366228